Sci PharmtechTPE:4119 +0.90%67 OCF Margin % is 17.70% as of Dec. 2025, which is 40% below its 10-year median of 29.41. GuruFocus rates TPE:4119 with a GF Score™ of 67/100 and a GF Value™ of NT$96.41 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 959 Drug Manufacturers companies, Sci Pharmtech ranks better than 69.55% on this metric.
The historical rank and industry rank for Sci Pharmtech's OCF Margin % or its related term are showing as below:
TPE:4119'
s OCF Margin % Range Over the Past 10 Years
Min: 16.4 Med: 29.41 Max: 56.47
Current: 16.4
During the past 13 years, the highest OCF Margin % of Sci Pharmtech was 56.47%. The lowest was 16.40%. And the median was 29.41%.
TPE:4119's OCF Margin % is ranked better than 69.55% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs TPE:4119: 16.40
Sci Pharmtech OCF Margin % Related Terms
Sci Pharmtech OCF Margin % Historical Data
* Premium members only.
The historical data trend for Sci Pharmtech's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sci Pharmtech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sci Pharmtech OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sci Pharmtech's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Sci Pharmtech's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sci Pharmtech (TPE:4119) has a OCF Margin % of 17.70% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sci Pharmtech and its competitors. This is 40% below median its historical median of 29.41. Over the past decade, Sci Pharmtech's OCF Margin % has ranged from 16.40 to 56.47. According to the industry distribution chart, Sci Pharmtech ranks #292 out of 959 companies in the Drug Manufacturers industry, placing it in the top 30.4%.
Is Sci Pharmtech's OCF Margin % too high?
Sci Pharmtech's current OCF Margin % of 17.70% is 40% below median its 10-year median of 29.41. Over the past 10 years, this metric has ranged from a low of 16.40 to a high of 56.47. The Drug Manufacturers industry median OCF Margin % is 9.95. Sci Pharmtech's value of 17.70% is 77.9% above this industry median. Based on the distribution chart, Sci Pharmtech ranks #292 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sci Pharmtech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sci Pharmtech's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sci Pharmtech ranks #292 out of 959 companies for OCF Margin %. This puts Sci Pharmtech in the upper half of its industry. The industry median OCF Margin % is 9.95. Sci Pharmtech's value of 17.70% is 77.9% above this benchmark. Historically, Sci Pharmtech's own OCF Margin % has ranged from 16.40 to 56.47 over the past decade. While the company's 10-year median is 29.41 vs. the industry median of 9.95, Sci Pharmtech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sci Pharmtech's current OCF Margin % of 17.70% is 77.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sci Pharmtech and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sci Pharmtech's current OCF Margin % is 17.70%, which is 40% below median its own 10-year median of 29.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sci Pharmtech stock overvalued right now?
Based on GuruFocus' analysis, Sci Pharmtech (TPE:4119) is currently considered Possible Value Trap. The stock's GF Value™ is NT$96.41, compared to a current price of NT$44.65 — trading 53.7% below its estimated fair value. The current OCF Margin % is 17.70%, which is 40% below median its 10-year median of 29.41 and 77.9% above the Drug Manufacturers industry median of 9.95. Sci Pharmtech's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sci Pharmtech (TPE:4119), the current OCF Margin % is 17.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sci Pharmtech (TPE:4119) Overvalued in 2026?
Based on GuruFocus' analysis, Sci Pharmtech stock appears to be undervalued.
The current stock price of NT$44.65 is trading 53.7% below its estimated GF Value™ of NT$96.41.
GuruFocus considers Sci Pharmtech to be Possible Value Trap.
Key valuation signals for TPE:4119:
OCF Margin %: 17.70% (40% below median its 10-year median of 29.41)
GF Value™: NT$96.41 vs. price of NT$44.65 (53.7% below fair value)
Industry Position: 77.9% above the Drug Manufacturers median (#292 of 959)
No single metric tells the full story. See the TPE:4119 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sales of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, Switzerland, Spain, Belgium, Netherlands, and others.
67GF Score
Get the complete analysis for TPE:4119
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4119 has been successfully added to your 
